Executive Summary
The professional decision, current reporting window and principal judgement.

WIB Report · Decision Intelligence
Decide whether to reconcile billing, improve sampling, trial source reduction or invest in treatment by separating enduring savings from transition cash flow.
Decision value
Inside the report
The professional decision, current reporting window and principal judgement.
Dated changes in rules or programme terms and their consequences for the next decision.
The operating boundaries, evidence and classification questions that affect implementation.
Worked tariff, transition-cash and investment comparisons with explicit assumptions.
Evidence and release conditions for sampling, source separation and treatment commitments.
What the primary sources establish, the qualifications that remain and their decision consequences.
Conditional direction, counterevidence and observable changes that would alter the judgement.
Specific records, milestones and the next review decision.
The research basis, evidence cutoff and scope limitations.
Selected intelligence
A concise preview of the evidence, implications and decisions examined in the full report.
A hypothetical Category 2 comparison shows how EUR6,000 of enduring annual savings can produce EUR564 of first-year capped savings under explicit eligibility and annual-assessment assumptions.
Settled-effluent COD and total suspended solids affect separate charge components; representative sampling, sanitary allowances and discharge boundaries must be consistent.
The report compares sampling, source separation and treatment through connection-specific evidence and release conditions, with compliance duties retained.
Who it is for
Evaluate the cash and enduring-charge basis for billing queries, trials and treatment expenditure.
Connect discharge data to production, source separation and compliant operating changes.
Frame representative sampling and whole-life treatment cases around the actual connection.
Product details
Method note
WIB synthesised current monitoring and selected authoritative primary evidence available through 22 October 2026. Original applied cases are explicitly hypothetical. Reported currencies, measurement bases and maturity states are retained.
Important scope limitation: Illustrative tariff and payback cases are hypothetical, not an audit of any customer invoice or treatment performance. Site category, samples, transition eligibility and annual assessment require connection-specific confirmation.
Purchase questions
A connection-level comparison of Ireland’s new trade-effluent charges, representative sampling and pretreatment investment.
1–22 October 2026, with an evidence cutoff of 22 October 2026.
This is a standalone decision report with applied cases and implementation screens. Recurring WIB intelligence editions provide continuing monitoring.
No. This report is a separate one-time US$49 purchase and is not included in a WIB intelligence subscription.
The complete report is supplied as a PDF, with a separate share-ready portrait cover PNG. The report is licensed to one named reader for internal business use, without redistribution; the cover may be shared to reference the report.
No. The purchase covers this edition only; future editions are sold separately.
WIB Report · 1–22 October 2026
Decide whether to reconcile billing, improve sampling, trial source reduction or invest in treatment by separating enduring savings from transition cash flow.